Medulax 50 mg (Tablet (Sustained Release))

Indications

• Relieves dry cough
• Pre & post-operative cough sedation
• Acute cough relief
• Whooping cough relief
• Relief from cough due to respiratory tract infections

Pharmacology

• Acts directly on brain's cough center
• Safe and non-sedating
• Rapid and complete absorption after oral administration
• Antitussive action

Dosage & Administration

• Adult dosage: 2-3 tablets daily
• Adult syrup dosage: 15 ml 4 times daily
• Children tablet dosage: 1-2 tablets daily
• Children syrup dosage: Varies by age
• Pediatric drops dosage: Varies by age

Interaction

• Avoid concomitant use with expectorants

Contraindications

• Hypersensitivity to the active ingredient

Side Effects

• Good tolerance observed
• Rare adverse reactions: rash, nausea, diarrhea, vertigo

Pregnancy & Lactation

• Avoid use during first trimester of pregnancy
• Caution during remainder of pregnancy
• Carefully weigh benefits against risks during breastfeeding

Precautions & Warnings

• Avoid concomitant use with expectorants
• Consult doctor if cough persists for more than 7 days (3 days in children under 12 years)

Overdose Effects

• Symptoms of accidental overdose: drowsiness, nausea, vomiting, diarrhea, loss of balance, hypotension
• Standard emergency procedures: activated charcoal, saline laxatives, cardio-respiratory resuscitation

Therapeutic Class

• Cough suppressant

Storage Conditions

• Keep away from light and moisture
• Store below 30°C
• Keep out of reach of children

Related Brands

• Medulax 7.5 mg/5 ml (Syrup) - nipro-jmi-pharma-ltd
• Supreno 7.5 mg/5 ml (Syrup) - kumudini-pharma-ltd
• Buratuss 5 mg/ml (Pediatric Drops) - beximco-pharmaceuticals-ltd
• Buratuss 7.5 mg/5 ml (Syrup) - beximco-pharmaceuticals-ltd
• Buratuss SR 50 mg (Tablet (Sustained Release)) - beximco-pharmaceuticals-ltd